Found 165 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2010
E. H Sahly, Patel, S., Atmar, R., Lanford, T., Dube, T., Thompson, D., Sim, B. K., Long, C., and Keitel, W., Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria is Not Endemic, Clinical and Vaccine Immunology, vol. 17, pp. 1552-1559, 2010.
M. Thera, Doumbo, O., Coulibaly, D., Laurens, M., Kone, A., Guindo, A., Traore, K., Sissoko, M., Diallo, D., Diarra, I., Kouriba, B., Daou, M., Dolo, A., Baby, M., Sissoko, M., Sagara, I., Niangaly, A., Traore, I., Olotu, A., Godeaux, O., Leach, A., Dubois, M., and Ballou, W., Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial, PLoS One, vol. 5, p. e9041, 2010.
S. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A., Rinella, P., Hill, H., Wolff, M., Schultze, V., Han, J., Scharschmidt, B., and Belshe, R., Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults, Vaccine, vol. 28, pp. 6367-6373, 2010.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
S. Gilmour, Sorensen, L., Anand, R., Yin, W., Alonso, E., and Consortium, T. Studies fo, School Outcomes in Children Registered in The Studies for Pediatric Liver Transplant (SPLIT) Consortium, Liver Transpl, vol. 16, pp. 1041-1048, 2010.
N. Oden, Van Veldhuisen, P., Scott, I., and Ip, M., SCORE Study Report 8: Closed Tests for All Pairwise Comparisons of Means, Drug Inf J, vol. 44, pp. 405-420, 2010.
L. Stadler, Bernstein, D., Callahan, T., Ferreira, J., Simone, G., Edwards, K., Stanberry, L., and Rosenthal, S., Seroprevalence of Cytomegalovirus (CMV) and Risk Factors for Infection in Adolescent Males, Clinical Infectious Diseases, vol. 51, pp. e76-e81, 2010.
J. S. Peterson, Specifying Methodes for Mean VA Calculations [letter], J Cataract Refract Surg, vol. 36, pp. 184-185, 2010.
B. Blodi, Domalpally, A., Scott, I., Ip, M., Oden, N., Elledge, J., Warren, K., Altaweel, M., Kim, J., Van Veldhuisen, P., and Group, S. C. O. R. E. Study Rese, Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Stereoscopic Color Fundus Photographs and Fluorescein Angiograms: SCORE Study Report 9, Archives of Ophthalmology, vol. 128, pp. 1140-1145, 2010.
2009
R. C. Brady, Treanor, J. J., Atmar, R. L., Keitel, W. A., Edelman, R., Chen, W. H., Winokur, P., Belshe, R., Graham, I. L., Noah, D. L., Guo, K., and Hill, H., Safety and Immunogenicity of a Subvirion Inactivated Influenza a/H5N1 Vaccine With or Without Aluminum Hydroxide Among Healthy Elderly Adults, Vaccine, vol. 27, pp. 5091-5095, 2009.
W. A. Keitel, Campbell, J. D., Treanor, J. J., Walter, E. B., Patel, S. M., He, F., Noah, D. L., and Hill, H., Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given Without or With Aluminum Hydroxide to Healthy Adults: Results of a Phase I-II Randomized Clinical Trial, J Infec Dis, vol. 198, pp. 1309-1316, 2009.
I. U. Scott, Van Veldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., Jumper, J. M., Figueroa, M., and Group, T. S. C. O. R. E. Stud, Score Study Report 1: Baseline Associations Between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion, Ophthalmology, vol. 116, pp. 504-512, 2009.
I. U. Scott, Blodi, B., Ip, M., Van Veldhuisen, P., Oden, N., Chan, C., Gonzalez, V., and Group, S. C. O. R. E. Study Inve, SCORE Study Report 2: Interobserver Agreement Between Investigator and Reading Center Classification of Retinal Vein Occlusion Type, Ophthalmology, vol. 116, pp. 756-761, 2009.
M. Ip, Oden, N., Scott, I., Van Veldhuisen, P., Blodi, B., Figueroa, M., Antoszyk, A., Elman, M., and Group, S. C. O. R. E. Study Inve, SCORE Study Report 3: Study Design and Baseline Characteristics, Ophthalmology, vol. 116, pp. 1770-1777 e1, 2009.
M. S. Ip, Scott, I. U., Van Veldhuisen, P., Oden, N. L., Blodi, B. A., Fisher, M., Singerman, L. J., Tolentino, M., Chan, C. K., and Gonzalez, V. H., SCORE Study Report 5: A Randomized Trial Comparing the Efficacy & Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion.., Archives of Ophthalmology, vol. 127, no. 9, pp. 1101-1114, 2009.
I. Scott, Oden, N., and Van Veldhuisen, P., SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated with Staked-on vs. Luer Cone Syringe Design, Am J Ophthalmol, vol. 148, pp. 725-732 e7, 2009.
A. Domalpally, Blodi, B., Scott, I., Ip, M., Oden, N., Lauer, A., and Van Veldhuisen, P., The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4, Arch Ophthalmol, vol. 127, pp. 1461-1467, 2009.
E. Chew, Lindblad, A., Clemons, T., and Group, A. - R. Eye Diseas, Summary Results and Recommendations from the Age-Related Eye Disease Study, Arch Ophthalmol, vol. 127, pp. 1678-1679, 2009.
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., and Vignati, L., Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy, Eye (Lond), vol. 23, pp. 209-214, 2009.